Suzhou Zelgen Biopharmaceuticals Co Ltd (688266 SHG) stock market data APIs
¥105.6157
-1.36(-1.3%)
as of September 17, 2025
Try our APIs with
free plan!
Suzhou Zelgen Biopharmaceuticals Co Ltd Financial Data Overview
Price chart is built with
Anychart
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers donafenib tablets; recombinant human thrombin for topincal use; jacktinib tablets; and recombinant human thyroid-stimulating hormone for injection; obeticholic acid magnesium tablets; ZG19018 tablets; ZG005 powder for injection; and alkotinib capsules for the treatment of liver cancer, non-small cell lung cancer, small cell lung cancer, colorectal cancer, thyroid cancer, and neuroendocrine cancer, as well as multiple therapeutic areas, such as bleeding, hepatobiliary diseases, and autoimmune diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.
Prev. Close
105.6157
Open
104.2569
High
109.9417
Low
103.2234
52 wk Range
53.19-134.17
Market Cap
28 059 M
Shares Outstanding
265 M
Revenue
668 M
EPS
-0.39
Beta
0.108
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Suzhou Zelgen Biopharmaceuticals Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Suzhou Zelgen Biopharmaceuticals Co Ltd data using free add-ons & libraries
Get Suzhou Zelgen Biopharmaceuticals Co Ltd Fundamental Data
Suzhou Zelgen Biopharmaceuticals Co Ltd Fundamental data includes:
- Net Revenue: 668 M
- EBITDA: -187 224 272
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-21
- EPS/Forecast: NaN
Get Suzhou Zelgen Biopharmaceuticals Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Suzhou Zelgen Biopharmaceuticals Co Ltd News
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
